U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2021
470
Name Type Language
SOTROVIMAB
USAN   INN  
Official Name English
sotrovimab [INN]
Common Name English
VIR7831
Code English
IMMUNOGLOBULIN G1 (438-LEUCINE,444-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VIR-7831 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIR-7831 .KAPPA.-CHAIN, DIMER
Common Name English
Sotrovimab [WHO-DD]
Common Name English
GSK4182136
Code English
IMMUNOGLOBULIN G1-KAPPA, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (2019-NCOV) SPIKE GLYCOPROTEIN (PEPLOMER PROTEIN, E2)),HUMAN MONOCLONAL ANTIBODY; .GAMMA.1 HEAVY CHAIN (1-457) (HOMO SAPIENS VH (IGHV1-18*01 (93%) (IGHD)-IGHJ5*01 (93%)) (8.8.
Common Name English
SOTROVIMAB [JAN]
Common Name English
GSK-4182136
Code English
VIR-7831
Code English
SOTROVIMAB [USAN]
Common Name English
Code System Code Type Description
FDA UNII
1MTK0BPN8V
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
INN
11766
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
SMS_ID
300000022271
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
WIKIPEDIA
Sotrovimab
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
CAS
2423014-07-5
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
DAILYMED
1MTK0BPN8V
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
NCI_THESAURUS
C177059
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
RXCUI
2550731
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
USAN
JK-80
Created by admin on Sat Dec 16 16:33:05 GMT 2023 , Edited by admin on Sat Dec 16 16:33:05 GMT 2023
PRIMARY
ACTIVE MOIETY
SOTROVIMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966